Skip to content

ENAMEL

Active
Private limited company·Activiteiten van tandartspraktijken· 4 yrs active
Kroninglaan 38 ·1200 Sint-Lambrechts-Woluwe, Belgium
KBO/BCE: BE 0785.904.688
Watch Print / PDF
Age4 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of ENAMEL is 0.3% (very low). The 2024 annual accounts show equity of €256k and a net result of €94k. Equity is growing by ~55.8% per year across the filed fiscal years. Its solvency ranks better than 88% of 6582 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 3 annual accounts.

Signals

3 signals · with evidence
Strong solvency vs sector
Solvency is in the sector's strongest quartile: better than 88% of 6582 peers (2024). A comfortable equity buffer.
View the sector comparison
Consistently profitable
Positive net result in the two most recent financial years (2023 and 2024).
View the result trend
Growing equity
Equity grew over 2022-2024. Profits are largely retained rather than distributed.
View the equity trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide
Deadline passed, not yet counted as missing
The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 15 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.
Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 31-07-2025, 0 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
How we compute the deadline
The year end is derived from 3 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 nothing on record not filed -
31-12-2024 31-07-2025 31-07-2025 on the day 2025-00338784
31-12-2023 31-07-2024 29-08-2024 29 d late 2024-00390102
31-12-2022 31-07-2023 30-08-2023 30 d late 2023-00383669

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
More than 3 years active
Founded in 2022, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.3% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector Young company +Higher-failure-rate region +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€94k+8.5%
Working capital€252k+62.0%

Annual accounts & ratios

Source: NBB · 2024
Annual accounts filed on 31-07-2025 with the NBB · fiscal year 2024 · micro
€0€50k€100kOperating result 2022: €92k€92kNet result 2022: €74k€74kOperating result 2023: €109k€109kNet result 2023: €87k€87kOperating result 2024: €119k€119kNet result 2024: €94k€94k202220232024
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing Equity: growth of ~55.8%/year over 3 fiscal years, indicative, assuming unchanged policy.
€0€200k€400k€600k2025: €346k (€325k - €366k)2026: €436k (€416k - €456k)2027: €526k (€506k - €547k)2022: €75k2023: €162k2024: €256k202220232024202520262027
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency 91.1% 66.7%
better than 88% of 6582 sector peers
Net result €94k €46k
better than 75% of 6576 sector peers
Equity €256k €79k
better than 85% of 6582 sector peers
Gross operating margin €121k €78k
better than 67% of 6584 sector peers
Total assets €281k €154k
better than 72% of 6585 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P88
2022: P80 · n=36842023: P85 · n=53462024: P88 · n=65822022 2024
Stable position over 2022-2024 · n=3684-6582
Net result P75
2022: P72 · n=36822023: P78 · n=53452024: P75 · n=65762022 2024
Stable position over 2022-2024 · n=3682-6576
Equity P85
2022: P58 · n=36842023: P77 · n=53482024: P85 · n=65822022 2024
Improving position over 2022-2024 · n=3684-6582
Gross operating margin P67
2022: P63 · n=36802023: P70 · n=53422024: P67 · n=65842022 2024
Stable position over 2022-2024 · n=3680-6584
Describes the position versus peers, not a forecast.
EBITDA
€121k
+9.1% 22-24
Net profit
€94k
+8.5% 22-24
Cash flow
€97k
+8.6% 22-24
Total assets
€281k
+51.6% 22-24
Equity
€256k
+58.0% 22-24
Working capital
€252k
+62.0% 22-24
Income taxes
€25k
+11.0% 22-24
Debt
€25k
+6.9% 22-24
Show 8 other metrics
Debt ≤ 1y
€25k
+6.9% 22-24
Current ratio
11.13
+44.9% 22-24
Quick ratio
11.13
+44.9% 22-24
Solvency
91.1%
+4.3% 22-24
Debt / equity
0.10
-32.4% 22-24
ROE
36.7%
-31.4% 22-24
ROA
33.5%
-28.5% 22-24
Interest coverage
1911.01
+18.5% 22-24
Figures by fiscal year
Fiscal year2024
Depositmicro
Revenue-
EBITDA€121k
Net profit€94k
Cash flow€97k
Staff costs-
Income taxes€25k
Dividends-
Total assets€281k
Equity€256k
Debt€25k
of which ≤ 1y€25k
of which > 1y-
Working capital€252k
Employees (FTE)-
Ratios (computed)
2024
Current ratio11.13
Quick ratio11.13
Working capital ratio90.0%
Solvency91.1%
Debt / equity0.10
Long-term debt ratio-
Interest coverage1911.01
Gross margin-
Net margin-
ROA33.5%
ROE36.7%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2024
Full annual accounts (18 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2024
Balance sheet, Assets
TOTAL ASSETS 20/58€281k
Fixed assets 21/28€3k
Tangible fixed assets 22/27€3k
Current assets 29/58€277k
Cash & bank 54/58€265k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€281k
Equity 10/15€256k
Contributions / capital 10/11€2k
Accumulated profits (losses) 14€254k
Amounts payable 17/49€25k
Amounts payable within one year 42/48€25k
Income statement
Gross operating margin 9900€121k
Operating result 9901€119k
Financial charges 65€64
Result before taxes 9903€119k
Income taxes 67/77€25k
Net result for the period 9904€94k
Result to be appropriated 9905€94k
This table shows the latest fiscal year. 2 prior years, with figures and ratios, belong to a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2024 · computed
100 / 100 Excellent
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

from the Crossroads Bank
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Kroninglaan 381200 Sint-Lambrechts-Woluwe

Establishment units

1 location
ENAMEL
Kroninglaan 38, 1200 Sint-Lambrechts-WoluweActiviteiten van tandartspraktijken
since 20222.331.326.605
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area177 m²
Buildings1
Building footprint93 m²
Volume (LiDAR)621 m³
Tallest building11.8 m · ±3 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21673D0150/00B048 Brussels 177 m² 1 · 93 m² 11.8 m · 3 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgian State Gazette · acts

0 of 1 acts read

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

The insolvency signals above come from a separate source; the KBO register is the second source and appears as the legal situation on this page.

Analysis

Snowflake analysis

financial profile on 5 axes
Health100Profitability100Solvency100Growth78Stability94
94 / 100

Exceptional profile, strong across almost every axis.

All 5 axes are computed from data Checked has read.

Health 100
Profitability 100
Solvency 100
Growth 78
Stability 94

Credit advice

verdict per customer and amount

May this customer buy amount X on invoice? Enter the amount and the payment term. This page computes a GREEN, AMBER or RED verdict from them, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Comparable size, same sector

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Tandartspraktijken86230Activiteiten van tandartspraktijken86230
Primary activity highlighted.
Names & trade names
Legal nameFR ENAMEL
Registered office
Kroninglaan 38
1200 Sint-Lambrechts-Woluwe, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.